Frankincense, derived from the resin of Boswellia trees, has been used in traditional medicine for centuries and is now the subject of growing scientific interest. Research suggests that boswellic acids, the primary active compounds in Boswellia sacra extract, may help modulate inflammatory pathways in the body, with studies indicating potential benefits for joint comfort, gut health, and respiratory function. Preliminary research has also explored its role in supporting cognitive function, particularly in relation to neuroinflammatory processes, though more large-scale human trials are needed to fully understand these effects. Overall, the existing body of evidence points to frankincense as a promising botanical supplement with a long history of traditional use now being examined through a modern scientific lens.
Compare this supplementResearch suggests that frankincense, particularly in the form of Boswellia serrata extracts and their active compound...
View studies →Research suggests that Boswellia serrata extract, the active ingredient in frankincense supplements, may support join...
View studies →Research suggests that frankincense has been noted in broader reviews of herbal and complementary approaches to respi...
View studies →Research suggests that Boswellia serrata, the botanical source of frankincense, may support cognitive function in mid...
View studies →Research suggests that Boswellia serrata (frankincense) may support gut health through anti-inflammatory, anti-tumor,...
View studies →These are commonly referenced dosage ranges for this supplement. They are not medical recommendations. Always consult a healthcare provider before supplementing.
| Form | Dose range | Frequency | Studied for | Source |
|---|---|---|---|---|
| Extract | 333–400 mg | Three times daily | Anti-inflammatory and joint health using standard Boswellia serrata extract | Commonly used dose range in clinical trials for arthritis and inflammatory conditions |
| Extract | 100–300 mg | Daily | Cognitive function and neuroprotection | Emerging clinical and preclinical research on Boswellia and cognitive outcomes |
| Extract | 300–500 mg | Twice daily | Gut health, including Crohn's disease and ulcerative colitis | Based on clinical trials evaluating Boswellia for inflammatory bowel disease |
| Extract | 100–250 mg | Three times daily | Joint health and osteoarthritis, using standardized AKBA-containing Boswellia serrata extract | Common in RCTs for osteoarthritis, including trials using 5-Loxin and Aflapin extracts |
| Extract | 400–800 mg | Twice daily | Respiratory health including asthma management | Dose range used in RCTs examining Boswellia serrata for bronchial asthma |